Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06469801
NA

ECMO ABI Detection With Hyperfine

Sponsor: Children's Mercy Hospital Kansas City

View on ClinicalTrials.gov

Summary

The primary objective is to characterize the prevalence and type of ABI following cannulation for pediatric patients who require ECMO support. The secondary objective is to describe the time course and rates of ABI using ultralow-field bedside MRI relative to both duration of ECMO support and clinical imaging obtained in routine care of pediatric ECMO patients.

Official title: Low-Field Bedside MRI for Detection of Acute Brain Injury in Pediatric Extracorporeal Membrane Oxygenation

Key Details

Gender

All

Age Range

0 Days - 17 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2024-07-23

Completion Date

2026-07-01

Last Updated

2025-08-15

Healthy Volunteers

No

Interventions

DEVICE

Hyperfine

Enrolled subjects will undergo a Hyperfine MRI exam, which is a portable, low-field MRI, at various timepoints during their clinical course on ECMO. Patients will undergo imaging within 36 hours of ECMO initiation/cannulation. Patients that remain on ECMO will have repeat imaging at 72-120 hours of ECMO therapy and again weekly for the duration of their ECMO course. Patients will also undergo a portable MRI within 24 hours of clinical head imaging, if applicable.

Locations (1)

Children's Mercy

Kansas City, Missouri, United States